Glycocalyx and Oxidative Stress in Endothelial Function (Part 2)
Recruiting
Observational Study
Coronary Heart Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 35 (estimated)
- Sponsor
- Josip Juraj Strossmayer University of Osijek · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The primary research objective of the project is to determine the role of eGC in microvascular reactivity in patients with coronary heart disease (CHD) before and after bypass grafting (cross-sectional study 2).The main objective of the project is to increase the excellence and interdisciplinarity of scientific work at MEFOS by connecting researchers from different scientific fields, improving con…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* adult patients of both sexes over 18 years of age
* Caucasian
* undergoing elective coronary artery bypass grafting (CABG)
* provided written informed consent
Exclusion Criteria:
* emergency surgery
* sepsis or severe systemic inflammation before surgery
* severe renal or he…
Contacts